Vaxxinity, Inc.
NASDAQ:VAXX
0.09 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.001 | 0.05 | 0 | 0.017 | 0 | 0.117 | 0.44 | 0 |
| Cost of Revenue
| 0.456 | 0.666 | 0.512 | 0.6 | 0.54 | 0.419 | 0.392 | 0.333 | 0.174 | 0.009 | 1.927 | 0.001 | 0 | 0.178 | 0.229 | 0 |
| Gross Profit
| -0.456 | -0.666 | -0.512 | -0.6 | -0.54 | -0.419 | -0.392 | -0.333 | -0.175 | 0.041 | -1.927 | 0.016 | 0 | -0.061 | 0.211 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 175 | 0.82 | 0 | 0.941 | 0 | -0.521 | 0.48 | 0 |
| Reseach & Development Expenses
| 7.764 | 7.91 | 8.345 | 11.424 | 13.018 | 12.468 | 10.664 | 11.478 | 17.158 | 23.616 | 18.944 | 11.688 | 8.461 | 7.867 | 2.414 | 0.002 |
| General & Administrative Expenses
| 3.43 | 5.535 | 6.082 | 7.384 | 7.806 | 7.3 | 6.56 | 6.686 | 30.695 | 6.7 | 5.924 | 8.584 | 2.764 | 5.122 | 3.614 | 0.001 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 3.43 | 5.535 | 6.082 | 7.384 | 7.806 | 7.3 | 6.56 | 6.686 | 30.695 | 6.7 | 5.924 | 8.584 | 2.764 | 5.122 | 3.614 | 0.001 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.667 | 0 | 0 | -2.667 | -0.98 | -2.786 | -1.024 | 0 |
| Operating Expenses
| 11.194 | 13.445 | 14.427 | 18.808 | 20.824 | 19.768 | 17.224 | 18.164 | 47.853 | 30.316 | 24.868 | 20.272 | 11.225 | 12.989 | 6.028 | 0.004 |
| Operating Income
| -11.65 | -13.445 | -14.427 | -18.808 | -20.824 | -19.768 | -17.224 | -18.164 | -47.854 | -30.275 | -26.795 | -20.256 | -11.225 | -12.694 | -5.817 | -0.003 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47,854 | -605.5 | 0 | -1,191.529 | 0 | -108.496 | -13.22 | 0 |
| Total Other Income Expenses Net
| 0.258 | -0.036 | 0.018 | 0.387 | 0.368 | 0.516 | -0.028 | -0.099 | 0.001 | -0.005 | -0.008 | -11.254 | -1.05 | -3.44 | -1.027 | -0.001 |
| Income Before Tax
| -11.392 | -13.145 | -13.977 | -18.421 | -20.456 | -19.252 | -17.252 | -18.263 | -48.191 | -30.389 | -26.91 | -32.021 | -12.719 | -16.465 | -7.06 | -0.004 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48,191 | -607.78 | 0 | -1,883.588 | 0 | -140.726 | -16.045 | 0 |
| Income Tax Expense
| 0.412 | 0.176 | 0.146 | -0.012 | 0.016 | -0.025 | 0.028 | -0.001 | 3.014 | 0.109 | 0.107 | -2.156 | -0.536 | -2.455 | 0.217 | 0 |
| Net Income
| -11.392 | -13.145 | -13.977 | -18.409 | -20.472 | -19.227 | -17.28 | -18.262 | -48.191 | -30.389 | -26.91 | -32.021 | -12.719 | -16.465 | -7.061 | -0.004 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48,191 | -607.78 | 0 | -1,883.588 | 0 | -140.726 | -16.048 | 0 |
| EPS
| -0.09 | -0.1 | -0.11 | -0.15 | -0.16 | -0.15 | -0.14 | -0.15 | -0.38 | -0.24 | -0.22 | -0.26 | -0.1 | -0.13 | -0.057 | -0.11 |
| EPS Diluted
| -0.09 | -0.1 | -0.11 | -0.15 | -0.16 | -0.15 | -0.14 | -0.15 | -0.38 | -0.24 | -0.22 | -0.26 | -0.1 | -0.13 | -0.057 | -0.11 |
| EBITDA
| -11.194 | -12.267 | -13.323 | -17.655 | -19.65 | -18.804 | -16.757 | -17.826 | -45.004 | -29.912 | -26.512 | -22.641 | -11.851 | -15.241 | -6.841 | -0.003 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45,004 | -598.24 | 0 | -1,331.824 | 0 | -130.265 | -15.548 | 0 |